生物样本库设备市场－全球产业规模、份额、趋势、机会和预测，依产品、应用（再生医学、药物研发及其他）、地区和竞争格局划分，2020-2030年预测

2024年全球生物样本库设备市场规模为499.7亿美元，预计2030年将以5.80%的复合年增长率成长至700.8亿美元。生物样本库设备涵盖了生物样本全面管理（包括采集、处理、储存和检索）所需的专用仪器和系统。此类别通常包括超低温冰箱、自动化液体处理设备和先进的样本管理软体。

主要市场驱动因素

对个人化和精准医疗日益增长的需求是全球生物样本库设备市场的主要驱动力。这种医疗模式根据患者的个别特征量身定制治疗方案，需要收集大量且种类丰富的优质生物样本。

主要市场挑战

建立和维护现代化生物样本库设施所需的大量初始资本投资，对全球生物样本库设备市场的成长构成了显着挑战。建造一流的生物样本库需要大量的资金用于购买专用仪器、先进的低温储存系统和复杂的样本管理软体。

主要市场趋势

人工智慧和机器学习技术在生物样本库设备中的应用，正在建构智慧系统，从而提升营运效率和预测能力。这些演算法优化了样本追踪，确保了精准的品质控制，并促进了复杂的资料分析，直接提高了生物样本的完整性和科研利用率。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球生物样本库设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（设备（低温储存系统、警报监控系统、其他）、介质和耗材）
  • 依应用领域（再生医学、药物研发、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美生物样本库设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲生物样本库设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太生物样本库设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲生物样本库设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲生物样本库设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球生物样本库设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Becton, Dickinson and Company
• Bio-Techne Corporation
• Hamilton Company
• Merck KgaA
• Lonza Group AG
• QIAGEN NV
• Stemcell Technologies Inc.
• Tecan Group AG
• Thermo Fisher Scientific Inc

第十六章：策略建议

第17章调查会社について・免责事项

The Global Biobank Equipment Market, valued at USD 49.97 Billion in 2024, is projected to experience a CAGR of 5.80% to reach USD 70.08 Billion by 2030. Biobank equipment encompasses specialized instruments and systems essential for the comprehensive management of biological samples, including collection, processing, storage, and retrieval. This category typically includes ultra-low temperature freezers, automated liquid handlers, and advanced sample management software.

Key Market Drivers

The increasing demand for personalized and precision medicine is a principal driver for the global biobank equipment market. This paradigm tailors medical treatments to individual patient characteristics, requiring extensive and diverse collections of high-quality biological samples. Biobanks provide these essential repositories, facilitating genomic sequencing, biomarker discovery, and targeted therapy development. The need for precise sample collection, processing, and long-term preservation directly elevates demand for specialized equipment, including advanced freezers and automated aliquotting systems.

Key Market Challenges

The substantial initial capital investment required for establishing and maintaining modern biobank facilities represents a notable challenge to the growth of the Global Biobank Equipment Market. Developing a state-of-the-art biobank necessitates significant financial resources for acquiring specialized instruments, advanced cryogenic storage systems, and sophisticated sample management software. This high upfront cost creates a considerable barrier for numerous entities, including smaller research institutions and emerging biotechnology companies, that may lack the extensive budgets needed to initiate or upgrade their biobanking operations.

Key Market Trends

AI and machine learning integration in biobank equipment is enabling intelligent systems for enhanced operational efficiency and predictive capabilities. These algorithms optimize sample tracking, ensure precise quality control, and facilitate complex data analysis, directly improving biospecimen integrity and utility for research. This advancement allows biobanks to manage extensive datasets, uncover subtle patterns, and accelerate biomarker discovery.

Key Market Players

• Becton, Dickinson and Company
• Bio-Techne Corporation
• Hamilton Company
• Merck KgaA
• Lonza Group AG
• QIAGEN N.V.
• Stemcell Technologies Inc.
• Tecan Group AG
• Thermo Fisher Scientific Inc

Report Scope:

In this report, the Global Biobank Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biobank Equipment Market, By Product:

• Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others)
• Media & Consumables

Biobank Equipment Market, By Application:

• Regenerative Medicine
• Drug Discovery
• Others

Biobank Equipment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• South America
  • Brazil
  • Argentina
  • Colombia
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biobank Equipment Market.

Available Customizations:

Global Biobank Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biobank Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others), Media & Consumables)
  • 5.2.2. By Application (Regenerative Medicine, Drug Discovery, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Biobank Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biobank Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Biobank Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Biobank Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Biobank Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biobank Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. France Biobank Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Biobank Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Biobank Equipment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Biobank Equipment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Biobank Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biobank Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Biobank Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Biobank Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Biobank Equipment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Biobank Equipment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. Middle East & Africa Biobank Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biobank Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Biobank Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Biobank Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. South America Biobank Equipment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biobank Equipment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Biobank Equipment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Biobank Equipment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biobank Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Techne Corporation
• 15.3. Hamilton Company
• 15.4. Merck KgaA
• 15.5. Lonza Group AG
• 15.6. QIAGEN N.V.
• 15.7. Stemcell Technologies Inc.
• 15.8. Tecan Group AG
• 15.9. Thermo Fisher Scientific Inc

16. Strategic Recommendations

17. About Us & Disclaimer